Results are imminent in biopharmaceutical company Opthea’s latest clinical trial evaluating the safety and efficacy of its lead drug candidate with Eylea in diabetic macular edema (DME) patients. Read more
Stimulus package to drive ‘big-ticket’ purchases
The Federal Government’s vast expansion the instant asset write-off threshold to $150,000 as part of its coronavirus stimulus package is set to benefit eyecare professionals seeking high value equipment.
Read more
Latest Optovue OCT device arrives in Australia
BOC Instruments has introduced Optovue’s latest optical coherence tomography (OCT) machine to the Australian market, combining numerous ophthalmic diagnostic functions into a single device. Read more
Survey: Device-dependence is altering visual behaviour
One in 10 Australians spend more than 10 hours per day looking at a screen, according to findings of a new Zeiss-commissioned study revealing the extent and risks of device dependence. Read more
Updated occupational optometry guide to help curb eye injuries
Optometry Australia (OA) has produced a free occupational optometry and safety eyewear guide to help eyecare professionals prevent patient injuries in the workplace. Read more
Novartis pursues PBS listing for Beovu
Novartis is working to ensure its newly-approved drug Beovu is accessible via the Pharmaceutical Benefits Scheme (PBS) at the earliest opportunity after expressing disappointment over an initial decision not to recommend it for the government-subsidised medicines program. Read more
Zeiss At Lisa tri family IOLs satisfy key performance measures
A meta-analysis of scientific studies evaluating Zeiss’ At Lisa tri family intraocular lenses (IOL) has offered new insight into its performance in terms of patient satisfaction, spectacle independence, visual acuity and predictability. Read more
Medical device industry expert joins Aussie OCT company
Melbourne-based OCT manufacturer Cylite has appointed accomplished medical device industry figure Ms Kylee Hall to its executive team as it prepares to bring its new system to market. Read more
Warby Parker launches its own contact lens
US-based online retailer of prescription spectacles Warby Parker has entered a new section of the ophthalmic market with its own brand of contact lenses. Read more
In pursuit of progressive perfection
Advances in lens design and manufacturing processes have spurred the development of the ‘premium’ progressive lens market. It has also created endless possibilities for lens makers and eyecare professionals to satisfy any patient who walks through their door. MYLES HUME reports. Read more